You are here

2020 Poster Session: A Virtual Experience

2020 Poster Session: A Virtual Experience

The Clinical TMS Society has been working hard over the last few months to create a virtual experience for the 2020 Annual Meeting Poster Session.

We are excited to announce that the posters will be available for online viewing through December 31, 2020. As the window to view the posters are limited, we encourage everyone to register asap, to receive the max allotted time.

We have a total of 58 authors/presenters sharing their critical insights and research findings. 

Earn up to a max of 14.5 hours of CME depending on how many posters you choose to view. 

Instructions on how to access the posters and obtain CME will be included in your confirmation email. 

Costs:

  • CTMSS Members: FREE
  • Non-Members: $50 USD

All registrations will be checked for membership.

Click here to view a list of confirmed posters.


Acknowledgment of Financial and/or In-Kind Commercial Support
No financial or in-kind commercial support was received for this educational activity.

Satisfactory Completion
Learners must review each poster chosen and take up to 15 minutes to absorb the information and complete an evaluation form to receive a certificate of completion.

Complete all posters you wish to view before completing the evaluation.

If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.  

Physicians

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Clinical TMS Society.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this enduring material for a maximum of 14.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Objectives - After Attending This Program You Should Be Able To

  1. Identify evidence for various TMS treatment approaches compared to standard TMS approach
  2. Discuss the effectiveness of TMS in various populations and settings
  3. Discuss predictive biomarkers and/or clinical markers of response to repetitive transcranial magnetic stimulation (rTMS) treatment

Disclosure of Conflict of Interest

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.  All of these relationships were treated as a conflict of interest, and have been resolved.  (C7 SCS 6.1-­‐6.2, 6.5)

All individuals in a position to control the content of CE are listed on the website. If their name is not listed below, they disclosed that they had no financial relationships with a commercial interest.

First Name

Last Name

Commercial Interest: Relationship

Linda

Carpenter

Janssen: Consultant, Neuronetics: Research Grant Overall Principal Investigator, Affect Neuro: Consultant, Neosync: Research Grant Site Principal Investigator, Affect Neuro: Research Grant Overall Principal Investigator, Janssen: Research Grant Site Principal Investigator, Nexstim: Research Equipment Loan, Neuronetics: Research Equipment Loan, Neuronetics: Consultant, Sage Therapeutics: Consultant, Neurolief: Consultant

Roman

Gersner

BrainsWay: Employee*

Geoff

Grammer

Greenbrook TMS: Scientific/Medical Advisory Board Member, Greenbrook TMS: Employee, Neuronetics: Stock Shareholder, Brainsway: Research Grant Site Principal Investigator

Natalie

Haustrup

Eli Lilly: Employee*

Karen

Heart

Neuronetics: Employee*

Joshua

Kuluva

Sunovion: Speakers Bureau

Joshua

Kuluva

Sunovion: Speakers Bureau

Owen

Muir

Brainsway: Research Funding, speaker

Kenneth

Pages

Neuronetics: Speakers Bureau

Randy

Pardell

Neuronetics: Other

Debra

Stultz

Jazz Pharmaceticuls: Speakers Bureau, Harmony Biosciences: Speakers Bureau

Aron

Tendler

Brainsway Ltd.: Consultant, Advanced Mental Health Care: Stock Shareholder, Aron Tendler MD PA: Stock Shareholder, Brainsway Ltd.: Stock Shareholder

Jeff

Voigt

Magstim: Consultant


* Employee relationships with commercial interest organizations were vetted and found to be unbiased.

August 27th, 2020 8:00 AM   through   December 31st, 2020 11:59 PM
Virtual Poster Session Costs
Timezone
Time Zone Pacific
Event Thumbnail
Thumbnail

Help spread the word

Please help us and let your friends, colleagues and followers know about our page: 2020 Poster Session: A Virtual Experience


You can also share the below link in an email or on your website.
https://www.clinicaltmssociety.org/civicrm/event/info?id=143&reset=1